New Bill seeks mandatory disclosure of payments from pharma companies to healthcare providers

It follows an RCSI report on the risk of conflicts of interest caused by payments from pharmaceutical companies to Irish healthcare organisations and professionals

• Sarah Taaffe-Maguire
• February 3, 2022

Department of Health questioned over money paid by big pharma to healthcare bodies and workers

Report from the Royal College of Surgeons says the HSE lacks clear oversight of payments which may be leading to reduced quality prescribing and increased costs

• Sarah Taaffe-Maguire
• December 16, 2021

RCSI report: Risk of ‘conflict of interest’ on pharma payments

Royal College of Surgeons’ latest research reveals ‘substantial potential for conflicts of interest in Irish healthcare’

• Sarah Taaffe-Maguire
• August 15, 2021